451 reports of this reaction
3.2% of all LIDOCAINE HYDROCHLORIDE ANHYDROUS reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for LIDOCAINE HYDROCHLORIDE ANHYDROUS, manufactured by Spectra Medical Devices, LLC. There are 451 FDA adverse event reports linking LIDOCAINE HYDROCHLORIDE ANHYDROUS to NAUSEA. This represents approximately 3.2% of all 13,967 adverse event reports for this drug.
Patients taking LIDOCAINE HYDROCHLORIDE ANHYDROUS who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among LIDOCAINE HYDROCHLORIDE ANHYDROUS users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for LIDOCAINE HYDROCHLORIDE ANHYDROUS:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 451 FDA reports for LIDOCAINE HYDROCHLORIDE ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.2% of all adverse event reports for LIDOCAINE HYDROCHLORIDE ANHYDROUS, making it one of the most commonly reported side effect.
If you experience nausea while taking LIDOCAINE HYDROCHLORIDE ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.